Atlas Trials

The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy

Clinical trial NCT00115895 · UNKNOWN

Trial details

NCT number
NCT00115895
Sponsor
University of Helsinki
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Thyroid Neoplasms
Start date
2000-01-01
Primary completion
2004-10-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.